The 6th Annual Conference on Psychedelics and Psychedelic Medicine will take place November 13–14, 2026, at the Starr Center at Massachusetts General Hospital in Boston.

Directed by Franklin King, MD, the conference provides a clinically focused examination of the rapidly evolving field of psychedelic medicine. The program explores current research and clinical applications of psychedelic-assisted therapies, with sessions covering pharmacology, neuroscience, therapeutic models, ketamine and esketamine, psychotherapy, psychosomatics, implementation challenges, spirituality, naturalistic use and clinical risk.

The conference is designed for clinicians and researchers across multiple disciplines, including psychiatrists, psychiatric nurse practitioners, social workers, clinical psychologists and other professionals interested in the theoretical and practical applications of psychedelics. MGH Academy

The program offers 11.75 AMA PRA Category 1 Credits™, 11.75 nursing contact hours, 11.75 social work continuing education hours, 11.75 participation hours and 11.75 psychologist CE credits, subject to the applicable accreditation requirements. MGH Psychiatry Academy

Key Program Highlights

Friday — November 13

Introduction, Neurobiology & Therapeutic Models

• 8:30 AM — Welcome & Introduction
• Psychedelic Pharmacology for Clinicians
• Psychedelic-Assisted Therapy: Evidence, Experience, and Ongoing Questions
• Cognitive Networks and Neuroscience of Depression Under Psychedelics
• Plant Medicines and the Psychedelome
• Advanced Meditation and the Third Wave of Meditation Research
• Ketamine and Esketamine in Academic Psychiatry
• Ketamine-Assisted Psychotherapy
• Psychoanalysis and Psychotherapy in Psychedelic Treatment
• Psychedelics in Cancer Care
• Panel discussions

Saturday — November 14

Clinical Expansion, Culture, Experience & Risk

• Implementation Challenges in Psychedelic Care
• Psychedelics & Borderline Personality Disorder
• MDMA-Assisted Therapy and Neuroimaging in Pain
• Psychedelic Churches and Sacred Use
• Population-Level Risks in Naturalistic Psychedelic Use
• Studying Psychedelics in Academic Medicine
• Music in Psychedelic Therapy Sessions
• Clinical Risks and Adverse Outcomes in Psychedelic Therapies
• Closing Remarks & Adjourn

The detailed program is published by MGH Psychiatry Academy.

Conference Topics

Use these as EventON tags/categories if available:

• Psychedelic Medicine
• Psychedelic-Assisted Therapy
• Psychiatry
• Psychopharmacology
• Neuroscience
• Depression
• PTSD
• Substance Use Disorders
• Ketamine
• MDMA
• Clinical Research
• Mental Health
• Medical Education
• Continuing Medical Education
• Psychology
• Healthcare